On September 19th, the National Council on Compensation Insurance (NCCI) hosted a webinar reviewing opioid prescribing patterns and the likelihood of continued opioid use among injured workers. Data presented came...
In late August, the FDA officially approved the Pfizer-BioNTech COVID-19 vaccine, which will officially be marketed as Comirnaty. This is the first FDA-approved vaccine for the prevention of COVID-19 and...
Leiters Health is voluntarily recalling 33 lots of IV vancomycin, phenylephrine, and fentanyl products at the user level due to superpotency because the bags may contain twice the labeled amount...
Teva Pharmaceuticals has voluntarily recalled specific lots of various strengths of fentanyl buccal tablets CII at the consumer level due to a labeling error. This recall has been initiated because...
...384 to 542, approximately 40%. Historically, research institutions have faced much difficulty completing the intensive, time-consuming application process to study marijuana that required cooperation with the DEA, the National Institute on Drug...
A new, non-opioid pain medication from Vertex Pharmaceuticals demonstrated positive results in Phase 2 proof of concept trials, showing promise for other potential indications in pain management. VX-548 was tested...
...13 GLP-1 RAs are FDA approved, with more currently in research and development. For ongoing coverage of the latest drug approvals and alerts impacting workers’ comp, visit Med Monitor online....
...of Women in Workers' Compensation Stay Informed Healthesystems will keep you current on what’s happening in workers’ comp with: Workers’ Comprehensive Our e-newsletter covers the latest clinical developments, policy changes,...
...They are committed to providing us with the right information at the right time so we can make well educated and informed decisions about workers’ compensation patients.” - Client Partner...
...depression, major depressive disorder, and PTSD. It appears that state legislatures across the nation have taken these latest developments in earnest, as so far ten states have introduced bills to...
Healthesystems is transforming the workers' compensation pharmacy and ancillary benefits management experience. Powered by state-of-the-art technology Supported by human-centered service Informed by industry expertise Inspired by a commitment to care...
Intelligence That Informs Thoughtful Solutions The workers’ compensation industry is constantly evolving in response to economic, political, and cultural changes. As new challenges arise, we must come up with new...
...engagements MedMonitor An up-to-date timeline of FDA approvals that could impact workers' comp View All MedMonitor Information Social Hub Check out our latest posts and activity View All Social Media...
...nausea Imuldosa should not be used in patients with active infections, tuberculosis, malignancies, hypersensitivity, and noninfectious pneumonia. For ongoing coverage of the latest drug approvals and alerts impacting workers’ comp,...
...This comes after reports of serious heart problems and deaths from much higher than recommended doses of loperamide. These adverse events are due to loperamide's increased use as a drug...
